Valuation: China Resources Pharmaceutical Group Limited

Market Cap 28.27B 3.6B 3.29B 3.04B 2.74B 5.16B 337B 5.37B 36.69B 14.51B 182B 13.52B 13.23B 574B P/E 2026 *
5.77x
P/E 2027 * 5.41x
Enterprise Value 77.51B 9.88B 9.01B 8.33B 7.52B 14.16B 923B 14.72B 101B 39.77B 498B 37.06B 36.28B 1,573B EV / Sales 2026 *
0.24x
EV / Sales 2027 * 0.21x
Free-Float
29.17%
Yield 2026 *
4.52%
Yield 2027 * 4.89%
1 day+0.56%
1 week-2.70%
Current month-2.91%
1 month-2.28%
3 months-7.22%
6 months-8.72%
Current year+1.12%
1 week 4.36
Extreme 4.365
4.58
1 month 4.36
Extreme 4.365
4.76
Current year 4.22
Extreme 4.22
6.53
1 year 4.22
Extreme 4.22
6.53
3 years 4.22
Extreme 4.22
7.11
5 years 3.18
Extreme 3.18
8.13
10 years 3.18
Extreme 3.18
13.16
Manager TitleAgeSince
President 47 26/08/2025
Director of Finance/CFO 54 13/06/2023
Corporate Secretary - 15/12/2025
Director TitleAgeSince
Director/Board Member 59 01/06/2016
Director/Board Member 70 20/06/2016
Chairman 55 29/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
1/4/20 Other

Chief Executive Officer

200,000 0.0032%
31/3/20 Other

Chief Executive Officer

100,000 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%-2.70%-8.91%-8.54% 3.58B
-1.64%-3.10%+35.21%+133.06% 1,261B
-1.11%-1.60%+37.96%+84.05% 671B
-1.65%-2.38%+23.13%+108.21% 518B
-0.69%+0.37%+31.53%+70.10% 387B
-3.39%-5.54%+44.17%+35.39% 353B
-1.35%-0.95%+28.90%+56.00% 300B
-1.13%-1.80%+0.59%+35.03% 283B
-2.54%-4.49%+29.98%+68.50% 248B
-0.51%-0.12%+33.30%+123.06% 211B
Average -1.36%-0.70%+25.59%+70.49% 424B
Weighted average by Cap. -1.56%-0.55%+31.38%+91.95%

Financials

2026 *2027 *
Net sales 328B 41.78B 38.1B 35.23B 31.79B 59.88B 3,904B 62.24B 425B 168B 2,107B 157B 153B 6,654B 341B 43.43B 39.61B 36.62B 33.05B 62.24B 4,058B 64.7B 442B 175B 2,190B 163B 160B 6,917B
Net income 4.82B 615M 561M 518M 468M 881M 57.45B 916M 6.26B 2.48B 31.01B 2.31B 2.26B 97.92B 5.18B 660M 602M 556M 502M 946M 61.67B 983M 6.72B 2.66B 33.29B 2.48B 2.42B 105B
Net Debt 49.24B 6.27B 5.72B 5.29B 4.78B 8.99B 586B 9.35B 63.9B 25.26B 316B 23.54B 23.05B 999B 42.53B 5.42B 4.94B 4.57B 4.12B 7.77B 506B 8.07B 55.2B 21.82B 273B 20.33B 19.91B 863B
Projected Income Statement - Annual - China Resources Pharmaceutical Group Limited
Logo China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.
Employees
84,000
Date Price Change Volume
18/11/26 HK$4.500 +0.56% 4,182,500
17/11/26 HK$4.475 -0.33% 3,292,362
16/11/26 HK$4.490 +2.16% 4,459,736
13/11/26 HK$4.395 -1.79% 5,785,000
12/11/26 HK$4.475 -1.43% 5,475,500
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - China Resources Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
4.500HKD
Average target price
6.489HKD
Spread / Average Target
+44.20%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - China Resources Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 3320 Stock